Cargando…

MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma

BACKGROUND: Glioma is the most common primary intracranial tumor and is associated with poor prognosis. Identifying effective biomarkers for glioma is particularly important. MXRA5, a secreted glycoprotein, is involved in cell adhesion and extracellular matrix remodeling and has been reported to be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Jin-Zhang, Zhang, Jin-Hao, Li, Jia-Bo, Yuan, Feng, Tong, Lu-Qing, Wang, Xu-Ya, Chen, Lu-Lu, Fan, Xiao-Guang, Zhang, Yi-Ming, Ren, Xiao, Zhang, Chen, Yu, Sheng-Ping, Yang, Xue-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211501/ https://www.ncbi.nlm.nih.gov/pubmed/34211612 http://dx.doi.org/10.1155/2021/6680883

Ejemplares similares

Identification of MXRA5 as a novel biomarker in colorectal cancer
por: WANG, GUANG-HUI, et al.
Publicado: (2013)

Identification and functional activity of matrix-remodeling associated 5 (MXRA5) in benign hyperplastic prostate
por: Xiao, He, et al.
Publicado: (2020)

Mxra8 is a receptor for multiple arthritogenic alphaviruses
por: Zhang, Rong, et al.
Publicado: (2018)

MXRA7 is involved in megakaryocyte differentiation and platelet production
por: Sun, Zhenjiang, et al.
Publicado: (2023)

PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma
por: Li, Haoyu, et al.
Publicado: (2021)

ITGB3BP is a potential biomarker associated with poor prognosis of glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

MXRA8 is an immune-relative prognostic biomarker associated with metastasis and CD8(+) T cell infiltration in colorectal cancer
por: Tan, Lulu, et al.
Publicado: (2023)

Role of MXRA8 in Ross River Virus Disease Pathogenesis
por: Ng, Wern Hann, et al.
Publicado: (2023)

Expression of the Mxra8 Receptor Promotes Alphavirus Infection and Pathogenesis in Mice and Drosophila
por: Zhang, Rong, et al.
Publicado: (2019)

Proteomic Architecture of Valvular Extracellular Matrix: FNDC1 and MXRA5 Are New Biomarkers of Aortic Stenosis
por: Bouchareb, Rihab, et al.
Publicado: (2021)

Loss of MXRA8 Delays Mammary Tumor Development and Impairs Metastasis
por: Simpson, Kaitlyn E., et al.
Publicado: (2023)

Significantly high expression of NUP37 leads to poor prognosis of glioma patients by promoting the proliferation of glioma cells
por: Liu, Zhendong, et al.
Publicado: (2021)

Expressions of glia maturation factor-β by tumor cells and endothelia correlate with neovascularization and poor prognosis in human glioma
por: Kuang, Xiao-yan, et al.
Publicado: (2015)

Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients
por: Liu, Zhendong, et al.
Publicado: (2021)

Expression of glioma-associated oncogene 2 (Gli 2) is correlated with poor prognosis in patients with hepatocellular carcinoma undergoing hepatectomy
por: Zhang, Dawei, et al.
Publicado: (2013)

MAGOH is correlated with poor prognosis and is essential for cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

EZH2 overexpression is associated with poor prognosis in patients with glioma
por: Zhang, Yanyang, et al.
Publicado: (2016)

Abnormal expression of HOXD11 promotes the malignant behavior of glioma cells and leads to poor prognosis of glioma patients
por: Wang, Jialin, et al.
Publicado: (2021)

Dissecting and analyzing the Subclonal Mutations Associated with Poor Prognosis in Diffuse Glioma
por: Bai, Ming, et al.
Publicado: (2022)

KDM2B overexpression correlates with poor prognosis and regulates glioma cell growth
por: Wang, Yiwei, et al.
Publicado: (2018)

MGME1 associates with poor prognosis and is vital for cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer
por: Zhang, Xiao‐Guang, et al.
Publicado: (2018)

Correlation of microrna-372 upregulation with poor prognosis in human glioma
por: Li, Gang, et al.
Publicado: (2013)

The Tropomyosin Family as Novel Biomarkers in Relation to Poor Prognosis in Glioma
por: Huang, Ke, et al.
Publicado: (2022)

Interleukin-1 receptor-associated kinase 4 as a potential biomarker: Overexpression predicts poor prognosis in patients with glioma
por: Wang, Jialin, et al.
Publicado: (2021)

BHK-21 Cell Clones Differ in Chikungunya Virus Infection and MXRA8 Receptor Expression
por: Yin, Peiqi, et al.
Publicado: (2021)

Highly expressed of SERPINA3 indicated poor prognosis and involved in immune suppression in glioma
por: Yuan, Qing, et al.
Publicado: (2021)

TERT Promoter Mutations Lead to High Transcriptional Activity under Hypoxia and Temozolomide Treatment and Predict Poor Prognosis in Gliomas
por: Chen, Chen, et al.
Publicado: (2014)

Serum SALL4 Is a Novel Prognosis Biomarker with Tumor Recurrence and Poor Survival of Patients in Hepatocellular Carcinoma
por: Han, Su-xia, et al.
Publicado: (2014)

The Higher Expression of CDCA2 Associated with Poor Prognosis in Glioma
por: Jin, Xin, et al.
Publicado: (2022)

Hyperglycemia is a strong predictor of poor prognosis in COVID-19
por: Liu, Sheng-ping, et al.
Publicado: (2020)

Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma
por: Zhao, Gang, et al.
Publicado: (2013)

Downregulation of CYP2E1 is associated with poor prognosis and tumor progression of gliomas
por: Ye, Liguo, et al.
Publicado: (2021)

Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma
por: Li, Yong, et al.
Publicado: (2020)

KLF11 Expression Predicts Poor Prognosis in Glioma Patients
por: Xi, Zhuo, et al.
Publicado: (2021)

Overexpression of Transforming Acidic Coiled Coil‑Containing Protein 3 Reflects Malignant Characteristics and Poor Prognosis of Glioma
por: Sun, Ying, et al.
Publicado: (2017)

Association between glioblastoma cell‐derived vessels and poor prognosis of the patients
por: Mei, Xin, et al.
Publicado: (2020)

High c-Cbl expression in gliomas is associated with tumor progression and poor prognosis
por: JING, ZHITAO, et al.
Publicado: (2016)

CD73 is associated with poor prognosis in HNSCC
por: Ren, Zhen-Hu, et al.
Publicado: (2016)

Increased DEF6 expression is correlated with metastasis and poor prognosis in human osteosarcoma
por: Zhang, Qiao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_83ao2gbm15v7ootlhlob25h1fo